Skip To Main Content
Noa Rotbart on Muck Rack

Noa Rotbart

As seen in: EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Noa

Contact Noa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ultrasound Guided Tattooing of Axillary Lymph Nodes in Patients Prior To Neoadjuvant Therapy, and Identification of Tattooed Nodes at the Time of Surgery

|
By Tanir M. Allweis, Noa Rotbart, Petach Tikva, Yael Rapson
| EJSO - European Journal of Surgical Oncology Verified
Tanir M. Allweis Noa Rotbart Yael Rapson Hana Cernik Inna Bukov Judith Diment Tehilla Menes Ahuva Grubstein Background: Breast cancer patients with lymph node (LN) metastases at diagnosis often undergo neoadjuvant Therapy (NAT). Identification of a LN which regressed after NAT remains a challenge, and the current tools for marking the LN are technically cumbersome.
Open in Who Shared Issue with article?

Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery

|
By Tehillah S. Menes, Tanir M. Allweis, Noa Rotbart
| EJSO - European Journal of Surgical Oncology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 Identification of tattooed node at surgery. Fig. 2 Flow chart of all included cases. Abstract Background Breast cancer patients with lymph node (LN) metastases at diagnosis often undergo neoadjuvant therapy (NAT). Identification of a LN which regressed after NAT remains a challenge.
Open in Who Shared Issue with article?
See all 2 articles